3/3
07:42 am
traw
Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil [Yahoo! Finance]
High
Report
Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil [Yahoo! Finance]
3/3
07:00 am
traw
Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil
High
Report
Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil
2/28
08:54 am
traw
Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule [Yahoo! Finance]
Medium
Report
Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule [Yahoo! Finance]
2/28
07:00 am
traw
Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule
High
Report
Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule
1/23
07:00 am
traw
Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu
High
Report
Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu
1/10
05:55 pm
traw
Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program
High
Report
Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program
12/30
08:05 am
traw
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval [Yahoo! Finance]
High
Report
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval [Yahoo! Finance]
12/30
08:00 am
traw
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval
High
Report
Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval
12/23
07:17 am
traw
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu [Yahoo! Finance]
Medium
Report
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu [Yahoo! Finance]
12/23
07:00 am
traw
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
High
Report
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu